| Central serous chorioretinopathy: recent findings and new physiopathology hypothesis A Daruich, A Matet, A Dirani, E Bousquet, M Zhao, N Farman, F Jaisser, ... Progress in retinal and eye research 48, 82-118, 2015 | 908 | 2015 |
| Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy M Zhao, I Célérier, E Bousquet, JC Jeanny, L Jonet, M Savoldelli, O Offret, ... The Journal of clinical investigation 122 (7), 2672-2679, 2012 | 402 | 2012 |
| Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study E Bousquet, T Beydoun, M Zhao, L Hassan, O Offret, F Behar-Cohen Retina 33 (10), 2096-2102, 2013 | 244 | 2013 |
| Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study E Bousquet, T Beydoun, PR Rothschild, C Bergin, M Zhao, R Batista, ... Retina 35 (12), 2505-2515, 2015 | 150 | 2015 |
| Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy E Bousquet, S Bonnin, S Mrejen, V Krivosic, R Tadayoni, A Gaudric Retina 38 (3), 629-638, 2018 | 136 | 2018 |
| PACHYCHOROID: an inherited condition? M Lehmann, E Bousquet, T Beydoun, F Behar-Cohen Retina 35 (1), 10-16, 2015 | 116 | 2015 |
| Correlation between cystoid spaces in chronic diabetic macular edema and capillary nonperfusion detected by optical coherence tomography angiography V Mané, B Dupas, A Gaudric, S Bonnin, A Pedinielli, E Bousquet, ... Retina 36, S102-S110, 2016 | 85 | 2016 |
| Differential regulations of AQP4 and Kir4. 1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina M Zhao, E Bousquet, F Valamanesh, N Farman, JC Jeanny, F Jaisser, ... Investigative Ophthalmology & Visual Science 52 (9), 6340-6347, 2011 | 83 | 2011 |
| Multimodal imaging-based central serous chorioretinopathy classification J Chhablani, FB Cohen, P Aymard, T Beydoun, E Bousquet, ... Ophthalmology Retina 4 (11), 1043-1046, 2020 | 77 | 2020 |
| Shift work: a risk factor for central serous chorioretinopathy E Bousquet, M Dhundass, M Lehmann, PR Rothschild, V Bayon, D Leger, ... American Journal of Ophthalmology 165, 23-28, 2016 | 71 | 2016 |
| Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation A Couturier, E Bousquet, M Zhao, MC Naud, C Klein, L Jonet, R Tadayoni, ... Molecular vision 20, 908, 2014 | 48 | 2014 |
| The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis E Bousquet, M Zhao, A Ly, G Leroux les Jardins, B Goldenberg, MC Naud, ... PLoS One 7 (11), e49036, 2012 | 44 | 2012 |
| Predictive factors of response to mineralocorticoid receptor antagonists in nonresolving central serous chorioretinopathy E Bousquet, M Dhundass, R Lejoyeux, A Shinojima, V Krivosic, S Mrejen, ... American journal of ophthalmology 198, 80-87, 2019 | 38 | 2019 |
| Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats JB Saliba, L Vieira, GM Fernandes-Cunha, GR Da Silva, SL Fialho, ... Investigative ophthalmology & visual science 57 (4), 1671-1679, 2016 | 32 | 2016 |
| Central serous chorioretinopathy imaging biomarkers SR Singh, C Iovino, D Zur, D Masarwa, M Iglicki, R Gujar, M Lupidi, ... British Journal of Ophthalmology 106 (4), 553-558, 2022 | 30 | 2022 |
| Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysis T Lenfant, S Salah, G Leroux, E Bousquet, V Le Guern, F Chasset, ... Rheumatology 59 (12), 3807-3816, 2020 | 30 | 2020 |
| Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence E Bousquet, M Zhao, A Daruich, F Behar-Cohen Experimental eye research 187, 107754, 2019 | 30 | 2019 |
| Choroidal imaging with swept-source optical coherence tomography in patients with birdshot chorioretinopathy: choroidal reflectivity and thickness AI Dastiridou, E Bousquet, L Kuehlewein, T Tepelus, D Monnet, S Salah, ... Ophthalmology 124 (8), 1186-1195, 2017 | 29 | 2017 |
| Choroidal mast cells in retinal pathology: a potential target for intervention E Bousquet, M Zhao, B Thillaye-Goldenberg, V Lorena, B Castaneda, ... The American journal of pathology 185 (8), 2083-2095, 2015 | 21 | 2015 |
| Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy A Matet, T Jaworski, E Bousquet, J Canonica, C Gobeaux, A Daruich, ... Scientific Reports 10 (1), 20175, 2020 | 14 | 2020 |
